Trefoil Therapeutics
Developer of corneal therapeutics designed to facilitate the treatment of ophthalmic diseases. The company's therapy is focused on leveraging its engineered fibroblast growth factor-1 protein technolo...
Valuation
$59.5M
Market implied
Share Price
N/A
Total Raised
$49.7M
Last Round
N/A